Overview
This page is for GPs (family doctors), endocrinologists, gynaecologists, urologists, surgeons, psychiatrists, psychologists, therapists and other mental-health staff who see a patient who has stopped, or wants to reverse, a gender transition. Detransition here means stopping or reversing social, hormonal or surgical transition steps, usually alongside a change in how the person understands their sex or gender.
Clinical guidance for starting transition is extensive. Guidance for stopping it is thin, scattered and mostly expert opinion. This page brings together what exists: who presents and how, what detransitioners say helped and harmed them, the published recommendations, the main medical questions (hormones, puberty, gonad removal, bones, fertility, sexual function), mental-health assessment, documentation and coding, and how to respond to regret and anger. It quotes detransitioners describing real clinical encounters, good and bad.
It does not replace specialist advice or local protocols. Where a topic is already covered in depth elsewhere on the wiki, this page summarises it and links out:
- Detransition healthcare: the guideline gap, finding care, loss to follow-up, insurance and emerging services
- Stopping testosterone and stopping estrogen and blockers: timelines and what does and does not revert
- Mental health and gender dysphoria: comorbidity, minority stress and diagnostic overshadowing
- Gender exploratory therapy: the exploratory approach and the debate around it
No validated clinical protocol for detransition exists anywhere. Most of what follows is ordinary medicine (menopause care, male hypogonadism, fertility work-up, psychiatric assessment) applied to an unusual history. The specific risk in this group is less a gap in technical knowledge than a clinician's reaction to the patient: disbelief, defensiveness, or sending them back to the service they have left.
Who presents, and how
Numbers and demographics
Nobody knows how many people detransition, because clinics rarely record it and most patients never tell them (Cohn 2023). What the available samples show:
| Source | Sample | Relevant findings |
|---|---|---|
| Littman 2021 | 100 detransitioners, online survey | 69% female; lived transitioned for 3.9 years on average; only 24% told their clinicians they had detransitioned; 55% felt they had not been adequately assessed before transition |
| Vandenbussche 2022 | 237 detransitioners, online survey | 92% female, average age 25; 54% reported three or more diagnosed conditions; only 18% felt they had enough support |
| Rackliff et al. 2025 | 957 people in the US and Canada with any experience of detransition | 79% female; 42% had later restarted transition; 13% always and 45% sometimes avoided health providers when they needed care |
| MacKinnon et al. 2022 | 28 Canadians, interviews | 18 female, 10 male; many stopped hormones abruptly without supervision; clinicians often unprepared |
| Hall et al. 2021 | 175 adults discharged from an English adult gender clinic | 6.9% met a definition of detransition within a short follow-up; 21.7% disengaged from care |
| Boyd et al. 2022 | One English general practice, 68 trans-identified patients | 8 of 41 who started hormones stopped (after about five years on average), over half with notes of regret or detransition |
| Roberts et al. 2022 | 952 people in the US military health system | About 30% stopped filling hormone prescriptions within four years; females on testosterone were about 2.4 times as likely to stop. Reasons were not recorded |
| Kettula et al. 2025 | All 9 adults referred to the Helsinki gender clinic for detransition in 2018–19 | Regret appeared seven years after first diagnosis on average; most had trauma and multiple psychiatric diagnoses |
Each sample is small, self-selected or defined differently. "Stopping hormones" in a pharmacy database is not the same thing as re-identifying with one's sex. Taken together they suggest that patients are typically young adults, more often female than male, often several years after starting treatment, and often with complex mental-health histories (Littman 2021; Vandenbussche 2022).
Two kinds of detransition
Expósito-Campos proposed a distinction that helps with triage (Expósito-Campos 2021):
| Type | What it means | Typical clinical needs |
|---|---|---|
| Core (primary) | The person no longer identifies as transgender and identifies with their sex again | Reversal care, grief and regret, reassessment of what drove the original distress |
| Non-core (secondary) | The person stops or reverses transition but still identifies as trans, for example because of side effects, cost, discrimination or wanting children | Safe cessation, managing side effects, sometimes a later restart |
The types are not fixed. Some people move from non-core to core, and some identify as non-binary for a while before identifying with their sex again. The practical lesson is to ask the patient which situation they are in rather than assume.
How they present
Many detransitioners do not go back to the clinic that treated them. NHS England's planning work for a detransition pathway rests on the Cass Review's recommendation that services recognise people "may not wish to re-engage with the services they were previously under" (NHS England). So the first contact is often a GP, a gynaecologist, a urologist, a fertility clinic or a mental-health service, and the presenting complaint may not be "detransition" at all. Common ways in are:
- symptoms of hormone deficiency after stopping hormones, especially after removal of the ovaries or testes
- erectile problems, pelvic pain, vaginal dryness or bleeding changes
- wanting to know whether they can still have children
- breast tissue (in men) or the wish for breast reconstruction (in women)
- depression, anxiety, grief or a crisis
- paperwork: a letter for a document change, or a wrong sex marker on the record
Shame shapes how the history is given. Some patients hide it:
I went to a gynecologist recently to see if my body is still capable of having a baby. I qas too ashamed to tell her I'm a detrans (I just said I had very high levels of testosterone for years and a double mastectomy). Which is a very dumb lie, I know. —Playful-Score-67, detrans female
The medical care post-detransition is the hardest, most shame-inducing thing for me. I have definitely had medical doctors pathologize me and have had awkward moments with staff around my appearance/voice. —L82Desist, detrans female
A neutral, routine question in the history ("Have you ever taken hormones or had surgery as part of a gender transition, and are you still taking anything?") makes disclosure easier than waiting for the patient to raise it.
What detransitioners say they need
In Vandenbussche's survey, the most common needs were help with mental-health problems linked to their gender distress, information about options other than medical transition (65% each), and help coping with regret (60%). Many also needed medical help with stopping or changing hormones, with complications, and with reversal procedures. Some 87% wanted to hear from other detransitioners (Vandenbussche 2022). In Rackliff and colleagues' larger North American survey, the commonest unmet needs in written answers were peer support and "providers who understand detransition" (29% each), personal support (22%) and mental-health care (16%). Forty-six answers asked specifically for advice on stopping hormones safely (Rackliff et al. 2025).
What patients describe as good care is usually simple. A doctor who takes the decision at face value, explains the options, checks safety and follows up:
She was seemed immediately concerned for my wellbeing, she asked if I was ok, if I was considering self harm, if I had someone to talk to, if I was seeing a therapist... She told me that I could choose to stop cold turkey with the potential of mood swings and headaches, but she did not make side effects seem dramatic. She said I could also choose to taper off for a few weeks for mood stability, but this was not necessary. There was absolutely no suggestion that I should continue T, or that they were going to abandon me if I discontinued T. —throwaway99550092, r/detrans user
A doctor who listens and learns from the patient:
She said yes so I explained all the side effects I'd been going thru since going off, and how the only information I could find abt detransing was on reddit forums like this one and niche websites that are admittedly not the most hospitable places at times... She took notes on everything, and I got my levels checked. I've had em checked a few times since then. —Cautious_Tadpole9773, questioning own gender identity
A service that stays open whichever way the patient goes:
They were very interested, and offered me one of their psychologists to talk to regularly. They are basically helping me sort out my gender and general wellbeing, no matter what direction I’m going. —UnionVisual2694, detrans female
And a generalist who does not need to be an expert to be useful:
My pcp is just a regular family doctor but she's been really helpful and willing to write prescriptions or referrals. —Reasonable-Path6843, detrans female
Common mistakes
The same failures recur across detransitioner accounts, interview studies and surveys. Rackliff and colleagues found that 43% of respondents said their providers never seemed knowledgeable about detransition, and only 7% said they always did, although many answered "not applicable" (Rackliff et al. 2025).
| Mistake | What it looks like | A better approach |
|---|---|---|
| Dismissal | Saying detransition is rare, not real, or "a narrative" | Treat it as a clinical situation with physical and psychological needs |
| Assuming retransition | "Call me when you start back on it" | Plan care for the decision the patient has made; leave the door open without predicting |
| Heavier scrutiny than for transition | Repeated "are you sure?"; demands for proof | Assess capacity and safety proportionately; stopping a drug rarely needs the gatekeeping that starting one does |
| Refusing or withdrawing care | Discharge, "we only see trans patients", blocked contact | Continue care, or arrange a named onward referral |
| Relabelling | "You're probably non-binary"; "gender is fluid" | Use the patient's own words for where they are now |
| Pathologising doubt | Calling doubt "internalised transphobia" | Explore the doubt like any other clinical material |
| Reading detransition as instability | Letters calling the patient unstable; urgent psychiatric referral by default | Assess mental state on its own merits |
| Defensiveness | Telling the patient to "take personal responsibility" | Listen first; separate your feelings about past care from today's needs |
Dismissal and disbelief
One doctor basically told me that detransition wasn’t a real thing. That it was a “narrative.” And I was like, I’m sitting right here, like sorry the word triggers you but what else am I supposed to call this? —brightescala, detrans female
I brought up that having a double mastectomy for gender reasons may be contributing to another issue I was having but the doctor quickly said that’s unlikely and I “made the right choice”, I just scoffed at her and said it’s the biggest regret of my life. She just stared and me and asked me my pronouns, I again scoffed and said I’m a woman, let’s move on. —Conscious_Limit1493, detrans female
Assuming the patient will go back
When I told my doctor at the follow up appointment I stoped testosterone and was detransitioning she told me it’s normal and most trans guys stop temporarily until they get used to the changes then go back on it a few months later. Then continued to tell me to call her when I start back on it in a few months. —amidnightsnak, detrans female
I told my endo that I was going off E and she told me she supports me but my guess is she expects me to go back on at some point. Which I might do, idk but it seems condescending nonetheless. —transitionalprogram, questioning own transition
Retransition does happen. In Rackliff's sample, 42% had stopped and later restarted a transition (Rackliff et al. 2025), and some trans people describe stopping and then finding they needed hormones after all:
I start T two years ago but got it into my head that no one would want me if Testosterone did all the changes so i went off T for three months. And then the bad dysphoria and crying on my couch all the time came back and I realized I needed T or dysphoria was going to eat me alive —Wonderwitch12, trans man (FTM)
The two experiences point to the same practice. Neither outcome should be assumed. A patient who returns to their sex wants care for that, not a standing invitation to restart; a patient who may restart wants honest information, not pressure either way. See retransition.
Asking for more certainty than transition required
When I told my doctor about deciding to detransition, our interactions became a lot colder. She straight-up told me I had to find a different doctor for all my primary care needs and gave off the vibe that she was upset with me. She actually put a lot more effort into getting me to think if I was "sure" about detransitioning than when I started transitioning in the first place. —RockHardFlabs, detrans
I've been asked this question by therapist. She also asked me "are you 100% sure?" 3 times probably. Which is weird, nobody asked me like this about transition. —Personal-Level-1970, detrans female
The asymmetry is partly built into guidance. WPATH's Standards of Care, Version 8, recommends against requiring psychotherapy before transition, but recommends a comprehensive multidisciplinary assessment for adults who detransition and want further hormonal or surgical intervention (Coleman et al. 2022). In a survey of gender surgeons, 91% said they would require a new mental-health assessment before reversal surgery (Narayan et al. 2021). Assessment before a new irreversible operation is reasonable. Stopping a medication is different: a patient can stop taking a drug at any time, and the clinical task is to make that safe.
Refusing or withdrawing care
I told my clinic when I was 17 because I wanted help getting off testosterone and possibly getting help with a referral to get my name changed back and to get reconstruction. they proceeded to completely drop me, tell me detransition doesn't happen, and then say they feel unsafe around me. They refused writing a note to let me legally transition and said nobody would do it for me. Also dropped me from the eating disorder clinic in the same hospital so I lost all resources to that. —AttorneyRich8118, detrans female
For a patient whose ovaries or testes have been removed, a refusal to prescribe their own sex hormones leaves them with none at all. More examples of clinics discharging patients are collected on detransition healthcare.
Relabelling the patient as non-binary
my previous therapist thought that because I took many steps to be FTM that means now I couldn’t possibly be just female now, that I had to be nonbinary. I have since found a therapist who’s more neutral and doesn’t try to “label” me one way or another. —Plutonicuss, detrans female
Last I spoke to them I told them I was detransitioning and they told me, essentially "oh you're probably nonbinary" and hung up. —shadowthehedgehoe, detrans
Some people who stop hormones really do see themselves as non-binary rather than detransitioned. A trans-masculine non-binary person who stopped testosterone wrote that "I don’t view this as detransitioning" and that "I wasn’t looking for someone to tell me how bad T was. I just wanted to know what to expect physically and emotionally" (jjackjj, non-binary (r/ftm)). That is a fair point, and it argues for the same rule: let the patient name their own situation. The harm in the accounts above came from the clinician supplying the label.
Treating doubt as internalised transphobia
Internalised transphobia is the idea that a trans person can absorb society's negative views of trans people and turn them on themselves. Detransitioners describe clinicians using it to close down questions that, in hindsight, were the real issue:
I was concerned about these things within myself and expressed them to my therapist who wrote them off as “internalized transphobia”... I kept saying I think this is just from trauma, etc etc, and they told me it wasn’t. —Dismal_Plant_8360, detrans female
The contrast is a therapist who stayed neutral:
When I started talking to my therapist about it, she decided to take a completely neutral stance to contrast between the very opinionated stances of friends and family... Thank god for my therapist, because she genuinely saved my life. She taught me how to cope with dysphoria without transitioning, something the trans community views as impossible and suicide inducing. —fresh-taco, detrans female
Treating detransition itself as a symptom
LOL my therapist argued with me when I brought up my identity as a detransitioner, too, and then passed on to my psychiatrist that they thought I would regret detransition, even though was very firm about my detransition and explained my feelings and beliefs in detail. —effever0, detrans female
A changed view of one's gender is not evidence of mental illness on its own, any more than the original trans identity was. Mental state should be assessed on its own terms (see mental-health assessment below).
Published care recommendations
No body has published a full clinical guideline for detransition. The table lists the main documents that make recommendations, from across the debate.
| Source | Type | What it recommends |
|---|---|---|
| Butler & Hutchinson 2020 (UK psychologists) | Debate article | Notes that "nothing exists" for clinicians working with detransitioners. Support without judgement; treat gender and sexual identity as able to change; attend to family and social life; offer mixed peer groups; keep medical teams available to help reverse treatment |
| Entwistle 2021 (former NHS gender clinic psychologist) | Debate reply | Systematic long-term follow-up of everyone given medical interventions; non-medical treatments for gender dysphoria "sorely needed" |
| Expósito-Campos 2021 | Conceptual paper | Distinguish core and non-core detransition; thorough mental-health assessment; honest consent covering unknowns; offer exploratory therapy as well as medical options; long-term follow-up; respond without judgement; write guidelines for both groups |
| MacKinnon et al. 2022 (JAMA Network Open) | Interviews, 28 people | Calls for clinical guidance on detransition, for clinicians not to shame patients who stop, and for research on clinicians' knowledge and on detransition-related stigma |
| MacKinnon et al. 2023 (PLOS ONE) | Same 28 interviews, re-analysed | A thorough informed-consent process with individualised options; participants wanted tailored, "neutral" care with mental-health support |
| MacKinnon, Expósito-Campos & Gould 2023 (BMJ) | Analysis article | Build non-judgemental detransition care into gender services; follow patients for at least 5–10 years, not 1–2; do not assume people lost to follow-up still identify as trans; use the words "detrans" and "detransition" |
| Irwig 2022 (endocrinologist, JCEM) | Commentary | Detransition is likely rising and is often missed because patients stop attending; endocrinologists should give full information on irreversible effects; care for those who detransition "should remain compassionate" |
| Jorgensen 2023 | Commentary | Recognise detransitioners as patients harmed by care, with ongoing needs; notes the Endocrine Society guideline gives no advice on stopping hormones safely |
| WPATH SOC-8 (2022) | International guideline | One statement (5.7): a comprehensive multidisciplinary assessment for adults who detransition and seek further hormonal or surgical treatment |
| COHERE Finland 2020 | National recommendation (minors) | First-line treatment for gender dysphoria is psychosocial support, psychotherapy as needed, and treatment of comorbid psychiatric disorders. Does not address detransition directly |
| Kettula et al. 2025 (Helsinki adult gender clinic) | Case series and service change | No referral needed to return; closer work with psychiatry; free short-term psychotherapy; staff training in neutrality; encourage patients to notify the clinic that they detransitioned |
| Socialstyrelsen 2022 (Sweden) | National guideline (children and adolescents) | Cites detransition among young adults as one reason for caution; "unconditional exploration of gender identity"; systematic screening for autism and ADHD; document all measures for follow-up |
| Cass Review rec. 25 / NHS England | National review and service plan | Provision for people considering detransition, "recognising that they may not wish to re-engage with the services they were previously under"; NHS England is developing an adult detransition pathway and ran a call for evidence in late 2025 (NHS England 2025) |
| RCGP 2025 (Royal College of General Practitioners) | Position statement | Notes "additional challenges in supporting those who, having received treatment for gender incongruence, find their transition goals have changed", that there are no guidelines, and that this group may not want to engage with the services that transitioned them; calls for specific support for people whose transition goals change |
| RANZCP 2023 (Royal Australian and New Zealand College of Psychiatrists, PS #103) | Position statement | Services should ensure access to hormonal or surgical treatment to reverse earlier treatment; psychiatrists should give individualised care, help patients understand their feelings about transition including grief and loss, and recognise that detransition is heterogeneous; the true regret rate is unclear |
Authors on different sides of the wider debate agree on more than one might expect:
- Stay non-judgemental. Every source above says this in some form.
- Do not discharge. Continuity matters, and so does a route back that does not run through the original clinic.
- Assess the whole person. Mental health, trauma, neurodevelopmental conditions, sexuality and social context, not only gender.
- Follow up for years. Regret and detransition typically surface years after treatment.
- Record it. Clinics cannot learn from outcomes they never count.
They disagree on causes and on what detransition says about transition care. MacKinnon and colleagues work within a gender-affirming framework and describe trans and detrans people as "more similar than different" (MacKinnon et al. 2023). Jorgensen and Entwistle read detransition as evidence that the affirmative model has caused harm (Jorgensen 2023; Entwistle 2021). For the individual clinician, the practical advice is much the same either way.
Hormone management
This section is an orientation, not a protocol. The detail of what changes back, and when, is on the testosterone cessation and estrogen cessation pages. Hormone decisions belong with a clinician who can order and interpret tests, ideally an endocrinologist, gynaecologist or urologist used to treating hormone deficiency in people of the patient's sex.
First questions
| Question | Why it matters |
|---|---|
| What was taken, at what dose, by what route, for how long, and when was the last dose? | Long-acting injections (e.g. testosterone undecanoate, estradiol esters, depot GnRH analogues) keep acting for weeks to months |
| Were the ovaries or testes removed? | Without gonads, there is no natural hormone production to recover |
| Were puberty blockers used, and at what pubertal stage? | Natal puberty may never have completed |
| Is the patient getting hormones from outside the clinic (online or "DIY")? | Doses and products may be unknown; see DIY hormones |
| What does the patient want? | Full return to their own hormones, a slower change, or a deliberate middle course |
Stopping cross-sex hormones (gonads intact)
Females stopping testosterone. Testosterone suppresses the pituitary signals to the ovaries (LH and FSH, luteinising and follicle-stimulating hormone). After it clears, the ovaries usually restart, but there can be weeks or months with low levels of both hormones, which patients experience as fatigue, low mood and menopause-like symptoms. No study has compared tapering with stopping abruptly. Practical points that recur in patient accounts and general endocrine practice:
- Ovulation can return before periods are regular, and testosterone is not a contraceptive. Discuss contraception.
- If periods have not returned after several months, investigate as for secondary amenorrhoea (absent periods), remembering that long-term testosterone can mask or mimic other causes.
- Persistent changes (voice, facial hair, clitoral growth, scalp hair loss) will not reverse with time; plan referrals rather than waiting.
Males stopping estrogen and anti-androgens. Estrogen shuts down the hypothalamic–pituitary–gonadal (HPG) axis, and anti-androgens block testosterone production or action. Many men describe testosterone and sexual function returning within weeks to months. Some do not:
My T has never returned to its pre-HRT levels, and I've been having consistent issues with erectile dysfunction that only started while I was on estradiol- it seems that my testes have just never recovered their old capacity and need some help, so I'm trying to get a prescription of clomid to reboot things. —MythicalDawn, detrans male
No study has followed testosterone recovery in male detransitioners. Data from men stopping androgen deprivation for prostate cancer suggest that longer suppression and older age make full recovery less likely (Borque-Fernando et al. 2023), but those men were much older and the comparison is loose. Testing testosterone, LH and FSH some weeks after stopping, and investigating persistent low levels as for any male hypogonadism, is the obvious approach. Treatments that restart the axis, such as clomiphene or hCG (human chorionic gonadotrophin), and testosterone replacement have different effects on fertility, so the patient's wishes about children should shape the choice. Breast tissue that persists after a year or more usually needs surgical referral.
The common failure is no monitoring at all:
Cold turkey. My doctor said this was fine and had no interest in assisting or instructing me; never a single blood test or anything of the sort. —throwaway99550092, r/detrans user
By contrast:
My NP who prescribed my hormones happily ordered some labs after about a year so we could check all my levels had returned to normal. —fell_into_fantasy, detrans female
MacKinnon's participants often stopped abruptly and without supervision, and clinics rarely followed up once they stopped attending (MacKinnon et al. 2022). A booked follow-up with blood tests is a cheap way to catch the patients whose own hormones do not come back.
Restarting natal puberty after puberty blockers
Puberty blockers (GnRH analogues) pause puberty. Most young people in Dutch clinic data who started blockers went on to cross-sex hormones: 87% in one cohort, with 3.5% stopping because they no longer wanted gender treatment (Brik et al. 2020). So few detransitioners have been on blockers alone, and the evidence base for this situation is very small.
Three scenarios need distinguishing:
- Blockers only, then stopped. Puberty is expected to resume, as it does when blockers are used for early (precocious) puberty, but that is a different population at a different age. How completely puberty catches up after blockade in mid-adolescence has not been studied in this group.
- Blockers followed by cross-sex hormones, gonads intact. The patient never went through their own puberty. Stopping cross-sex hormones may allow natal puberty to start, possibly in the early or mid-twenties. Some patients and clinicians consider inducing it with the patient's own sex hormones under paediatric or adult endocrine supervision, as is done for delayed puberty.
- Blockers, cross-sex hormones and gonadectomy. There is no natal puberty to restart. Lifelong replacement of the patient's own sex hormones is the only route to its effects.
Patients' accounts describe partial or irregular recovery:
After going off the blockers it took a while until my period started again and even then only irregularly (which I still struggle with, but its getting better) and my breast have quite shrunken. —dramaticskinnybitch, detrans female
I'm underdeveloped due to being on puberty blockers since a teenager. I'll always be small framed. Puberty doesn't just restart once ceasing the medication, and activists say it's reversible. —Dear-Shift-7636, detrans male
Two known risks shape the work-up:
- Bone. In a re-analysis of England's early blocker study, about a third of 24 teenagers had abnormally low hip bone density after two years (Biggs 2021). In an Amsterdam follow-up of 75 adults treated with blockers then hormones, spine bone density in males given estrogen stayed below where it started, and 9–18% had spine density far below normal for their age at around 28 (van der Loos et al. 2023). A baseline DEXA scan (dual-energy X-ray absorptiometry, the standard bone density test) is reasonable for anyone with a history of blockers or long periods of low sex hormones.
- Fertility. In testicular tissue from 214 trans women at surgery, none of the 29 who started blockers in early puberty had mature sperm (de Nie et al. 2022). Fertility potential after early blockade followed by estrogen is uncertain and should be assessed, not assumed.
See puberty blockers.
After removal of the gonads
Patients who had both ovaries or both testes removed (gonadectomy) cannot recover their own hormones. Stopping cross-sex hormones without replacement leaves them with almost no sex hormones, the equivalent of untreated surgical menopause or castration. This is the most clinically urgent group.
Women after oophorectomy. Medically, this is surgical premature ovarian insufficiency (POI, loss of ovarian function before 40). The 2024 international guideline on POI recommends hormone replacement at least until the average age of natural menopause, for symptoms and to protect bone and cardiovascular health (ESHRE 2024). If the uterus was also removed, estrogen alone is standard; if not, a progestogen is needed to protect the womb lining. Some women also use a small dose of testosterone within the female range. Patients describe the switch as hard and say a menopause specialist was what helped:
My doctor didn’t want to do it, so she sent me to an ob/gyn who specializes in perimenopause and HRT for women. That was perfect for me. Estrogen alone was dreadful. I had really bad mood swings, hot flashes, low energy and low libido. —L82Desist, detrans female
But I was really lucky to find a doctor who understood that when I said I wanted to go back to living as female, I didn’t mean that I would like to just stop presenting as a guy. —motaneul, detrans female
Some describe having to justify estrogen in a way no woman after oophorectomy for other reasons would be asked to:
Now I have to go about proving I’m a woman just to get the hormones that were there to begin with. —Greatwhitesharkbait, self-questioning
Men after orchiectomy. This is male hypogonadism after surgery, managed with lifelong testosterone replacement, as for men who lose their testes to cancer. The Endocrine Society's testosterone guideline gives the standard approach to dosing and monitoring (Bhasin et al. 2018).
I’ve been on T for 2 years since an orchiectomy. Sure you’ll need to be on it for life but you have no choice as your body needs to take or hormone. Many guys who have had testicular cancer are in the same boat. —pupreno, detrans male
Gaps between stopping one hormone and starting the other are where harm happens:
I did this for two years and got osteopenia in my 20s. —CandidEg2, detrans male
The Endocrine Society's 2009 transition guideline already suggested bone density measurement in those who stop hormones after gonadectomy (Hembree et al. 2009). A minority of patients choose to stay on the cross-sex hormone, or a mixture, after gonadectomy while living as their sex. That is a legitimate choice to support with monitoring.
Summary
| Situation | Main tasks | Likely referral |
|---|---|---|
| Female, ovaries intact, stopping testosterone | Contraception; follow-up bloods; investigate absent periods | Gynaecology if periods do not return |
| Male, testes intact, stopping estrogen and anti-androgen | Testosterone, LH, FSH after some weeks; investigate persistent low levels | Endocrinology or urology/andrology |
| Blockers in adolescence | Bone density; puberty assessment; fertility assessment | Endocrinology |
| Female after oophorectomy | Estrogen replacement (plus progestogen if uterus present) without a gap | Menopause or POI clinic, gynaecology |
| Male after orchiectomy | Testosterone replacement without a gap | Endocrinology |
Mental-health assessment and comorbidities
The full evidence is on mental health and gender dysphoria. The short version for assessment:
- Comorbidity is the norm. In Vandenbussche's survey, 70% reported depression, 63% anxiety and 33% post-traumatic stress disorder (Vandenbussche 2022). In the Helsinki series, 89% had mood disorders, 78% anxiety disorders, 56% borderline personality disorder and 78% eating-disorder symptoms, and six of nine had been sexually abused or raped (Kettula et al. 2025). Littman and colleagues found 79% had ever self-harmed (Littman et al. 2024).
- Neurodevelopmental conditions matter. In the English adult clinic review, coexisting neurodevelopmental disorders were linked to about six times the odds of not completing care as planned (Hall et al. 2021). Four of six women in Lomax and Butler's UK interviews had an autism diagnosis (Lomax & Butler 2025). Sweden's guideline calls for systematic screening for autism and ADHD (Socialstyrelsen 2022). See autism.
- Problems often came first. In Finnish register data, gender-referred young people were already far more likely to need specialist psychiatric care before referral (45.7% vs 15.0% of controls), and medical transition did not reduce that need (Ruuska et al. 2026).
- Hormone changes affect mood. Stopping testosterone, and the gap before natural hormones return, can bring low mood that is hormonal rather than a sign the decision was wrong. Missing hormones after gonadectomy can do the same.
Many detransitioners say these conditions were noticed and then put down to gender dysphoria (diagnostic overshadowing):
But as soon as I started talking about myself, this "doctor" said that all my mental pain will go away when I start hormones and change my documents. —thistle_ev, detrans female
A single mention of the word ‘trauma’ in my doctor’s appointment at the gender clinic led to the professional response “and you can see someone else about that”. No referral given to see this supposed ‘someone else’. —evergone3, r/detrans user
Trans patients describe the mirror image, where mental illness is used as a reason to doubt their identity:
All the mental health workers who found out I'm trans argued with me that I can't be trans because I'm not miserable enough. —documentremy, trans man (FTM)
Both kinds of account describe the same mistake: a clinician deciding what the psychiatric history means before exploring it with the patient. For detransitioners, the task now is to treat the conditions directly and to help the patient make sense of what drove the original transition, without imposing a verdict.
What a good assessment covers
- Risk. Suicidal thoughts and self-harm, asked directly, as the GP in an earlier quote did. Detransition can bring isolation from former friends and communities as well as grief.
- Current psychiatric conditions. Depression, anxiety, PTSD, eating disorders, obsessive-compulsive disorder, dissociation, psychosis and substance use, each treated on its own terms.
- Neurodevelopmental screening where not already done.
- Trauma history. Including sexual abuse, which is common in published detransitioner samples.
- Sexuality. Some detransitioners describe internalised homophobia, or discomfort with being same-sex attracted, as part of why they transitioned (Littman 2021; MacKinnon et al. 2023). See internalised homophobia.
- Body image and persisting dysphoria. Distress about the sexed body may continue after detransition, and new distress about changes from treatment may appear.
- Grief, regret and identity. See handling regret and anger below.
- Social situation. Lost friends, family relationships, partners, work and documents.
Choosing therapy
Patients often ask for a therapist who neither affirms nor opposes trans identities. Some name trauma-focused therapy; gender exploratory therapy is the approach most often mentioned on /r/detrans, and the debate over it is covered on that page. The therapist's stance appears to matter more to patients than the school:
My therapist wasn't affirming and kept me on track to deal with my depression and self destructive thoughts first. I am very grateful for that. —DarichUbish, desisted female
The support directory lists exploratory therapists and detransition peer groups, which Vandenbussche's respondents rated highly (Vandenbussche 2022).
Fertility and sexual function referrals
These are often the issues patients find hardest to raise. Ask directly. The fertility and sexual function pages cover the evidence in detail.
Fertility
Females. Women with ovaries and a uterus who stop testosterone often recover fertility. In a survey of 41 trans men who gave birth after transitioning, 61% had taken testosterone and 88% used their own eggs (Light et al. 2014). That is a self-selected sample, not a recovery rate. Detransitioners describe ordinary tests as the starting point:
Ask your doctor for a hormone test including follicle stimulating hormone. It’s a standard test and you should have no problem with insurance coverage (in the US). —rose_creek, detrans female
Women who had a mastectomy will not be able to breastfeed. A published case of a detransitioned woman describes grief over this and poor maternity care, including a midwife telling her to "just formula feed" (Gribble et al. 2023). Maternity teams should be told about the history and prepared to discuss feeding options and grief.
Males. Estrogen and anti-androgens suppress sperm production, and recovery is uncertain after long use or after blockers in early puberty (de Nie et al. 2022). Semen analysis once testosterone has recovered, with referral to andrology or a fertility clinic if it is abnormal, is the standard route. Testosterone replacement suppresses sperm production, so men who want children need specialist advice before starting it.
After gonadectomy, fertility is gone unless eggs, sperm or tissue were stored. Patients may need help finding out whether anything was stored, and grief support.
Sexual function
| Problem | Common in | Typical first steps |
|---|---|---|
| Vaginal dryness, pain, atrophy | Women who took testosterone, especially after oophorectomy | Topical (vaginal) estrogen; gynaecology; pelvic floor physiotherapy |
| Pelvic pain | Women on or after testosterone | Gynaecological assessment |
| Erectile dysfunction, low libido, reduced ejaculate | Men after estrogen and anti-androgens | Hormone tests; urology or andrology |
| Pain or loss of function after genital surgery | Patients after vaginoplasty, phalloplasty or metoidioplasty | Specialist urology or reconstructive surgery |
| Breast or chest problems | Women after mastectomy; men with breast growth | Plastic surgery referral |
Vaginal estrogen appears under-used: fewer than 5% of trans men in one large survey reported ever using it, though 65% reported genital pain during sex (Tordoff et al. 2023). Detransitioned women describe it helping:
I had mild symptoms--dryness mostly--that my doctor noticed and was prescribed estradiol vaginal cream. It has helped a LOT. —Shh_YouSawNothing, detrans female
Among men, recovery of erectile function after stopping estrogen is often described as fairly quick, but not always complete:
It mostly returned after I stopped (1.5 years on E, ~8 months off) but my libido still has yet to fully recover. —TheDrillKeeper, detrans male
Documentation, records and coding
What to record
The BMJ authors recommend using the words "detrans" and "detransition" and not assuming that patients lost to follow-up still identify as trans (MacKinnon et al. 2023). The Helsinki clinic asks detransitioners to tell the clinic, because the information helps clinicians understand outcomes (Kettula et al. 2025). Detransitioners report clinics refusing to record detransition as the reason for discharge, or closing files without noting it (see detransition healthcare). Good practice is to record:
- that the patient has stopped or reversed transition, in their own words, with the date
- every intervention received (hormones with dates and doses, blockers, surgeries), because later clinicians need it
- current hormone status and plan
- which organs are present (uterus, cervix, ovaries, breasts, prostate, testes), since this drives screening and diagnosis
- the reason for discharge from gender services, if that happens
Sex markers, reference ranges and screening
A record that still shows the patient's former gender can cause practical harm. Laboratory reference ranges may be applied for the wrong sex, and automated screening recalls may be missed or sent wrongly. The RCGP notes that a trans man may not be recalled for cervical screening and calls for NHS systems to record sex at birth as well as gender (RCGP 2025). Detransitioners describe the reverse problem:
I went to get a breast and cervical screening recently and for some reason the records still said "male", I was there in a dress and makeup using a female name. —neongrayjoy, detrans female
When a patient asks to change their record back, check that screening programmes, results and history carry across. In the UK, changing the recorded gender has historically meant a new NHS number, which can separate a patient from parts of their history. For legal documents, see changing legal sex back.
Diagnosis and billing codes
No ICD-10, ICD-10-CM or ICD-11 code describes detransition. Gender diagnoses (ICD-10 F64.x; ICD-11 HA60, "gender incongruence of adolescence or adulthood") describe the original condition, not the reversal. Clinicians usually code what the patient now has. In the US ICD-10-CM, codes that can describe common situations include:
| Code (ICD-10-CM) | Meaning | Typical use |
|---|---|---|
| Z87.890 | Personal history of sex reassignment | Records the history |
| E89.40 / E89.41 | Asymptomatic / symptomatic postprocedural ovarian failure | Hormone replacement after oophorectomy |
| E89.5 | Postprocedural testicular hypofunction | Testosterone replacement after orchiectomy |
| Z90.13 | Acquired absence of bilateral breasts and nipples | Breast reconstruction after mastectomy |
| Z79.890 | Hormone replacement therapy | Ongoing replacement |
Sources: ICD10Data Z87.890, E89.41, E89.5, Z90.13. Check local coding rules and payer policy; this is not billing advice.
Sex-specific codes can be rejected if they do not match the sex on file. Medicare instructs institutional providers to report condition code 45 ("ambiguous gender category") so that sex-related edits are bypassed, and professional claims use a KX modifier (CMS transmittal R1877CP). A detransitioned patient who works as a medical coder suggested this may be why some practices keep labelling detransitioners as trans or non-binary:
It might be related to billing and coding. I’m a coder and at my facility we have to put in a special code for trans/NB patients that allows us to code gendered conditions (like pregnancy or genital surgery). —Expensive-Web-2989, detrans female
Coverage is uneven. In the US, plans covering mastectomy must cover reconstruction under the Women's Health and Cancer Rights Act, but insurers apply this unevenly after transition-related mastectomy, and some plans exclude detransition outright. Texas SB 1257 now requires plans that cover transition to cover reversal and adverse effects. Details are on detransition healthcare. Some patients are told to get a new gender dysphoria diagnosis so that reversal can be billed as gender-affirming care. Clinicians should be wary of entering a diagnosis the patient does not have.
Handling regret and anger
Regret varies
Not every detransitioner regrets transition. In MacKinnon's Canadian interviews, 67% of those who had medically transitioned expressed no regret, 22% regret and 11% mixed feelings (MacKinnon et al. 2022). In Littman's survey, recruited largely from detransition communities, about half reported strong or very strong regret (Littman 2021). The samples differ, and both groups exist. A survey of surgeons proposed three types of regret: "true gender-related" regret, social regret (for example from rejection or discrimination), and medical regret from complications or function (Narayan et al. 2021). Asking which applies helps; so does accepting that a patient may regret some interventions and not others. See transition regret.
Anger at clinicians
Anger is common, and much of it is aimed at the professionals involved in transition. Clinicians who see these patients will sometimes be the target, either as the original prescriber or as a stand-in for the profession.
You were literally a child, so the adults in your life –especially the doctors and therapist who pushed you to this – failed you horribly. The only reason people don’t want you to be angry is because they don’t want to be held accountable for stuff that should get them sued. —Shiro_L, detrans male
Many describe the anger easing with time, and say it sits on top of grief:
I had so much anger and resentment for my doctors and therapists in the beginning, especially because I couldnt even contact the woman who administered my T to give her a piece of my mind. This anger has also lessened slightly. —throwaway99550092, r/detrans user
Until you can process the anger of the grief, you won’t be able to get to the root, which is a deep and profound sadness around your loss of ability to conceive a child. —delusionalxx, detrans female
One woman described how her therapist reframed it:
she tells me that when i get angry about things that have already happened, it's a part of me realizing that it was wrong, that it's normal, that the adults around me failed me, and that those emotions indicate i haven't stopped caring about myself. that's a good thing. —neitherdreams, desisted female
Responding without defensiveness
The response patients describe as most damaging is defensiveness: shifting blame back onto them, or withdrawing.
The first thing my last therapist told me when I wanted to discuss my detransition was that I need to take personal responsibility. Even though I made a bunch of disclaimers saying I don’t blame anyone (and I don’t!) —illinoisbeau, detrans female
The responses they describe as healing are acknowledgement and practical help, sometimes including an apology:
recently she actually apologized for how my treatment was handled. She also acknowledged that I was very misinformed by my original doctor and that she should have re-explained to me what the treatment was actually doing to me. —man_on_the_moon44, detrans female
Fear of litigation is real; some detransitioners have sued, and in January 2026 a New York jury found a psychologist and a surgeon liable in the first US detransitioner malpractice case to reach a verdict (see detransitioner lawsuits). Several patients interpret clinicians' withdrawal as self-protection. Withdrawing care tends to make patients angrier, and refusing care is itself a clinical risk.
| Instead of | Try |
|---|---|
| "You chose this." | "That sounds like it has been really hard. What do you need from me now?" |
| "Most people are happy with their transition." | "Your experience matters, whatever other people's outcomes are." |
| "Are you sure? You might change your mind again." | "Let's make a plan for stopping safely, and we'll review it together." |
| "You should go back to the gender clinic." | "I can look after this, and I'll refer you to [named specialist] for [specific issue]." |
| "Have you thought about being non-binary?" | "How would you describe where you are now?" |
| Silence or discharge after a complaint | Acknowledge, document, and keep the clinical relationship going if the patient wants it |
If you were involved in the patient's transition, it may be right to hand over care. If you do, make it an active referral to a named clinician, not a discharge.
Limits of the evidence
- No trials, no guideline. Nothing here has been tested in a clinical trial. Recommendations come from small qualitative studies, surveys, case series and expert opinion.
- Self-selected samples. The main surveys recruited online, largely through detransition communities (Littman; Vandenbussche) or through LGBTQ networks and gender clinics (MacKinnon; Rackliff). They capture different people and give very different pictures of regret.
- Majority female. Most samples are 70–90% female, so evidence on men is thinner.
- Indirect hormone evidence. Recovery data mostly come from other populations: trans people pausing hormones to have children, men after prostate cancer treatment, women with premature ovarian insufficiency, and children treated for early puberty.
- Anecdotes show what happens, not how often. The quotes on this page come from people who chose to post on Reddit. They illustrate real encounters, not their frequency.
- Fast-moving policy. NHS England's pathway, US state laws and service changes are developing quickly.
Related pages
- Detransition healthcare: finding care and follow-up
- Stopping testosterone
- Stopping estrogen and blockers
- Mental health and gender dysphoria
- Gender exploratory therapy
- Puberty blockers
- Fertility and transition
- Sexual function after hormones and surgery
- Hysterectomy, orchiectomy and mastectomy
- Transition regret and retransition
- Healing and recovery
- Informed consent in gender medicine
- Gender clinics and clinicians: a guide for parents
- Support directory and study archive
References
- Bhasin, S. et al. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. source.
- Biggs, M. (2021). Revisiting the effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria. Journal of Pediatric Endocrinology and Metabolism. study page, source.
- Borque-Fernando, Á. et al. (2023). Testosterone Recovery after Androgen Deprivation Therapy in Prostate Cancer: Building a Predictive Model. source.
- Boyd, I., Hackett, T. & Bewley, S. (2022). Care of Transgender Patients: A General Practice Quality Improvement Approach. Healthcare. study page, source.
- Brik, T. et al. (2020). Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria. Archives of Sexual Behavior. study page, source.
- Butler, C. & Hutchinson, A. (2020). Debate: The pressing need for research and services for gender desisters/detransitioners. Child and Adolescent Mental Health. study page, source.
- Centers for Medicare & Medicaid Services. Transmittal R1877CP: condition code 45 and KX modifier for sex-specific edits. source.
- Cohn, J. (2023). The Detransition Rate Is Unknown. Archives of Sexual Behavior. study page.
- Coleman, E. et al. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health. study page.
- Council for Choices in Health Care in Finland (COHERE/PALKO) (2020). Medical Treatment Methods for Dysphoria Related to Gender Variance in Minors (unofficial translation). source.
- de Nie, I. et al. (2022). Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women. Human Reproduction. study page, source.
- Entwistle, K. (2021). Debate: Reality check – Detransitioner's testimonies require us to rethink gender dysphoria. Child and Adolescent Mental Health. study page, source.
- ESHRE, ASRM, CRE-WHiRL & IMS (2024). Evidence-based guideline: Premature Ovarian Insufficiency. source.
- Expósito-Campos, P. (2021). A Typology of Gender Detransition and Its Implications for Healthcare Providers. Journal of Sex & Marital Therapy. study page, source.
- Gribble, K. D., Bewley, S. & Dahlen, H. G. (2023). Breastfeeding grief after chest masculinisation mastectomy and detransition: A case report with lessons about unanticipated harm. Frontiers in Global Women's Health. study page, source.
- Hall, R., Mitchell, L. & Sachdeva, J. (2021). Access to care and frequency of detransition among a cohort discharged by a UK national adult gender identity clinic. BJPsych Open. study page, source.
- Hembree, W. C. et al. (2009). Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. source.
- Irwig, M. S. (2022). Detransition Among Transgender and Gender-Diverse People—An Increasing and Increasingly Complex Phenomenon. Journal of Clinical Endocrinology & Metabolism. study page, source.
- Jorgensen, S. C. J. (2023). Iatrogenic Harm in Gender Medicine. Journal of Sex & Marital Therapy. study page, source.
- Kettula, K. et al. (2025). Gender Dysphoria and Detransitioning in Adults: An Analysis of Nine Patients from a Gender Identity Clinic from Finland. Archives of Sexual Behavior. study page, source.
- Light, A. D. et al. (2014). Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstetrics & Gynecology. study page, source.
- Littman, L. (2021). Individuals Treated for Gender Dysphoria with Medical and/or Surgical Transition Who Subsequently Detransitioned: A Survey of 100 Detransitioners. Archives of Sexual Behavior. study page, source.
- Littman, L., O'Malley, S., Kerschner, H. & Bailey, J. M. (2024). Detransition and Desistance Among Previously Trans-Identified Young Adults. Archives of Sexual Behavior. study page, source.
- Lomax, J. & Butler, C. (2025). Narratives of Adults Registered Female at Birth Who Started a Medical Transition and Later Detransitioned. Archives of Sexual Behavior. study page, source.
- MacKinnon, K. R. et al. (2022). Health Care Experiences of Patients Discontinuing or Reversing Prior Gender-Affirming Treatments. JAMA Network Open. study page, source.
- MacKinnon, K. R. et al. (2023). Exploring the gender care experiences and perspectives of individuals who discontinued their transition or detransitioned in Canada. PLOS ONE. study page, source.
- MacKinnon, K. R., Expósito-Campos, P. & Gould, W. A. (2023). Detransition needs further understanding, not controversy. BMJ. study page, source.
- Narayan, S. K. et al. (2021). Guiding the conversation—types of regret after gender-affirming surgery and their associated etiologies. Annals of Translational Medicine. study page, source.
- NHS England (2024). Children and young people's gender services: implementing the Cass Review recommendations. source.
- NHS England (2025). Call for evidence: a clinical pathway for adults who have previously undergone a gender transition and who wish to detransition. source.
- Rackliff, K. et al. (2025). "Providers had no idea what to do with me": A mixed-methods analysis of detransition/retransition support, care, and information needs among sexual and gender minority individuals. International Journal of Transgender Health. study page, source.
- Roberts, C. M. et al. (2022). Continuation of Gender-affirming Hormones Among Transgender Adolescents and Adults. Journal of Clinical Endocrinology & Metabolism. study page, source.
- Royal Australian and New Zealand College of Psychiatrists (2023). The role of psychiatrists in working with Trans and Gender Diverse people (Position Statement 103). source.
- Royal College of General Practitioners (2025). The role of GPs in transgender care. source.
- Ruuska, S.-M. et al. (2026). Psychiatric Morbidity Among Adolescents and Young Adults Who Contacted Specialised Gender Identity Services in Finland in 1996–2019: A Register Study. Acta Paediatrica. study page, source.
- Socialstyrelsen (2022). Care of children and adolescents with gender dysphoria: Summary of national guidelines. source.
- Tordoff, D. M. et al. (2023). Testosterone use and sexual function among transgender men and gender diverse people assigned female at birth. American Journal of Obstetrics and Gynecology. study page, source.
- van der Loos, M. A. T. C. et al. (2023). Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones. JAMA Pediatrics. study page, source.
- Vandenbussche, E. (2022). Detransition-Related Needs and Support: A Cross-Sectional Online Survey. Journal of Homosexuality. study page, source.
Last updated:
Suggest an Article or an Improvement
Spotted something missing, unclear or wrong on this page, or have an idea for a related article? Let us know and we'll take a look.
Related pages:
- Desistance: Leaving a Trans Identity Before Medicalising
What desistance is, what childhood and adolescent follow-up studies show, the link with same-sex attraction, and how desisters describe stopping.
- Gender Exploratory Therapy: Evidence and Detrans Views
What gender exploratory therapy is, how it differs from affirmation and conversion, what the evidence shows, and what detransitioners say they needed.
- Healing After Detransition: Grief, Acceptance, Recovery
How detransitioners describe healing: grief for permanent changes, anger and shame, body acceptance, life without labels, therapy, peer support and setbacks.
- Detransitioner Lawsuits: Cases, Claims and Outcomes
Known detransitioner lawsuits worldwide: claims, defendants and status as of October 2026, plus the legal issues, criticism and detrans views on suing.
- Detransitioned Men: Experiences, Numbers and Needs
What is known about men who detransition: who they are, why they transitioned and stopped, the medical aftermath, shame, relationships and support.
- Detransition Processes: Triggers, Stages and Steps
How detransition unfolds: turning points, hidden doubt, the stages people describe, medical, social and legal steps, timelines and partial paths.
- How Common Is Detransition? Rates, Follow-Up and Unknowns
How often people detransition or stop treatment: every major estimate, what it measured, the time lag, and why loss to follow-up leaves the true rate unknown.
- Retransition After Detransition: Meaning and Evidence
Retransition means resuming a gender transition after detransition — not pausing one. Who retransitions, why, and why the word is contested.
- Support for Detransitioners: Groups, Services, Directories
What support exists for detransitioners: peer groups, online communities, clinicians, lawyers and crisis lines, with each service's orientation labelled.
- Transition Regret: Meaning, Evidence, and Lived Experience
What transition regret is, how it differs from detransition, why the '1% regret' figure is contested, the psychology of regret, and detransitioners' accounts.